New Delhi: The expert panel of Drug Controller General of India (DCGI) on Thursday recommended that emergency use authorization be granted to the COVID-19 vaccine Corbevax for children in the age group of 5 to 12 years.
Corbevax, developed by Hyderabad-based firm Biological-E, is India’s first indigenously-developed RBD protein sub-unit vaccine against the coronavirus.
It is being administered to children in the age group of 12 to 14 from March 16, 2022.
Meanwhile, the government panel has sought more data from Bharat Biotech before granting emergency use approval to Covaxin among children aged 5-12.
The 5-12 age group is yet to brought under the nationwide inoculation drive.
Bhubaneswar: Odisha Chief Minister Mohan Charan Majhi on Wednesday held a meeting with district Collectors…
Bhubaneswar: The Odisha Cabinet on Wednesday approved a new scheme “Goal for Management and Treatment…
Berhampur: A 62-year-old man and his wife were on Wednesday murdered allegedly by the husband’s…
Bhubaneswar: Sky gazers are in for a treat as the last supermoon also known as…
Bhubaneswar: The Odisha government on Wednesday decided to form an inter-ministerial committee to resolve various…
Chennai: The release of Suriya and Bobby Deol starrer highly -anticipated ‘Kanguva’ had hit uncertainty…
Mumbai: Popular comedy talk show ‘The Great Indian Kapil Show’, hosted and produced by Kapil…
Balasore: Amid reports of infighting and groupism in Biju Janata Dal (BJD) after its debacle…